Imexpharm named Top #1 Best Place to Work in Vietnam’s pharmaceutical sector

The Imexpharm Pharmaceutical Joint Stock Company was recognized on November 19 as the Top #1 best workplace among medium-sized enterprises in the Pharmaceutical, Medical Equipment, and Healthcare sector.

This was the second consecutive year it has earned the distinction, reflecting its commitment to creating a supportive environment where employees can thrive, stay engaged, and enjoy their work.

The Best Places to Work in Vietnam rankings, organized annually by Anphabe and supported by the Vietnam Chamber of Commerce and Industry (VCCI), is based on a survey of over 65,000 employees, 253 CEOs, and HR Directors from 700+ companies in 18 sectors.

The Anphabe survey, which was conducted from May to August and involved 1,612 respondents from the pharmaceutical sector, put Imexpharm as the best workplace among medium-sized enterprises in Vietnam’s Pharmaceutical, Medical Equipment, and Healthcare sector. The company also moved up 29 spots, to 25th place among the Top 100 Best Places to Work in Vietnam among medium-sized businesses.

It also excelled in the Employer Brand Health Check Scorecard, scoring 12.6 per cent on the Employer Brand Attractiveness Index, significantly higher than the industry average of 109 per cent. Its brand awareness reached 85.2 per cent, above the industry average of 81.5 per cent. Furthermore, 8.3 per cent of job candidates showed interest in applying to Imexpharm, compared to the industry average of 5.5 per cent. The proportion of top talent interested in working at Imexpharm was 129 per cent higher than the industry average, highlighting the company’s appeal in a competitive sector.

Commitment to a philosophy

Imexpharm’s philosophy of “People are the Most Valuable Asset” focuses on creating a transparent, supportive, and rewarding workplace. The company has developed numerous training and team-building initiatives centered on three core areas: professional expertise, physical health, and mental resilience. These efforts ensure that employees have opportunities for career development and personal growth.

From January to November 2024, Imexpharm conducted 14 onboarding training sessions, 324 internal training courses with over 15,780 participants, and 75 training sessions, both domestic and international, involving more than 1,760 employees. These programs have enhanced leadership, management, and technical skills in areas such as research and development, quality management, and marketing.

In addition to professional training, the company also fosters a collaborative, dynamic work environment through team-building activities, sporting events promoting healthy living, and leadership workshops to help employees achieve a work-life balance. Recognition programs, such as monthly outstanding employee awards, motivate continuous improvement and contribution.

Investing in human resources for sustainable growth

Looking ahead to 2025, Imexpharm plans to implement strategies to attract and retain top talent. This will include enhancing salary, bonus, and benefit packages, along with the introduction of long-term incentive programs for key employees. The company will also speed up its digital transformation to streamline human resources management, reduce administrative burdens, and build a robust database of potential candidates to enhance competitiveness.

“I am grateful that we continue to offer competitive salaries and benefits to over 1,400 employees, even amid a challenging business environment,” said Pharmacist Tran Thi Dao, General Director of Imexpharm. “I want to thank our team for their hard work and dedication, which have contributed to Imexpharm’s success. We will continue to focus on career development, training, and fostering a culture of excellence, trust, and success.”

A strong, supportive work environment has enabled Imexpharm to drive growth despite challenges in the pharmaceutical industry. For the first nine months of 2024, the company reported a 12 per cent increase in revenue, reaching VND1.553 trillion ($62.12 million), with pre-tax profit of VND252 billion ($10.08 million) and EBITDA of VND334 billion ($13.36 million).

Imexpharm’s ongoing dedication to its employees and the industry has earned it multiple prestigious accolades, including the Ngoi Sao Thuoc Viet (Vietnam’s Leading Pharmaceutical Star) from the Ministry of Health, Top 50 Best-Listed Companies from Forbes Vietnam, and Top 50 Most Effective Companies in Vietnam and Top 50 Sustainable Development Enterprises from Nhip Cau Dau Tu magazine.